Court: U.S. District Court
Location: Washington
Hagens Berman Sobol Shapiro LLP filed a class action lawsuit on behalf of purchasers of the securities of Northwest Biotherapeutics Inc. between July 9, 2006 and July 16, 2007, seeking to pursue remedies under the Securities Exchange Act of 1934.
The complaint charged Northwest Biotherapeutics with violations of the Exchange Act. According to the complaint, during the Class Period, Northwest Biotherapeutics issued materially false and misleading statements about its products.
Please contact HBSS if you have information about this case or believe you could be a class member. Steve Berman or Reed Kathrein of Hagens Berman can be reached via e-mail at info@hbsslaw.com.
RECENT UPDATES:
June 16, 2009 - The U.S. District Court in Seattle gave final approval to a settlement in the case.
July 2, 2008 - The U.S. District Court in Seattle denied the defendant's motion to dismiss allowing the class action against Northwest Biotherapeutics to move forward. Please check the website regularly for additional updates on the case.
| SHARE: |
|
| CONTACT US | CYCLING TEAM | TERMS AND CONDITIONS | FIRM BROCHURE | SECURITIES BROCHURE | FOLLOW US ONLINE: |
|
|
|
|
|
